Literature DB >> 16333103

Comparison of the sodium hydroxide specimen processing method with the C18-carboxypropylbetaine specimen processing method using independent specimens with auramine smear, the MB/BacT liquid culture system, and the COBAS AMPLICOR MTB test.

Eduardo Padilla1, José M Manterola, Victoria González, Charles G Thornton, M Dolores Quesada, M Dolores Sánchez, Miguel Pérez, Vicente Ausina.   

Abstract

A study was performed to diagnose tuberculosis by smear, culture, and nucleic acid amplification. The study was comprised of two independent arms. Each arm used a different specimen processing method; in one arm, all specimens were processed with N-acetyl-l-cysteine-sodium hydroxide, and in the other arm, all specimens were processed with C(18)-carboxypropylbetaine and lytic enzymes. In each arm, all processed sediments were split for analysis by auramine smear, by culture using the MB/BacT liquid culture system and solid media, and by nucleic acid amplification using the COBAS AMPLICOR MTB test. In the N-acetyl-l-cysteine-sodium hydroxide arm, 1,468 specimens were analyzed: 65 were smear positive; 88 and 42 were culture positive for Mycobacterium tuberculosis and nontuberculous mycobacteria, respectively; and 103 were PCR positive. Relative to cultures positive for M. tuberculosis, the sensitivity and specificity of the smear were 68.2% and 99.6%, respectively, and those of PCR were 75.0% and 97.3%, respectively. In the C(18)-carboxypropylbetaine study arm, 1,423 specimens were analyzed: 44 were smear positive; 82 and 31 were culture positive for M. tuberculosis and nontuberculous mycobacteria, respectively; and 91 were PCR positive. The sensitivity and specificity of the smear were 48.8% and 99.7%, respectively, and those of PCR were 78.0% and 98.0%, respectively. When the two arms were compared, C(18)-carboxypropylbetaine specimen processing significantly increased the number of smear-negative and culture-positive specimens and significantly increased the PCR sensitivity among this same group of specimens while at the same time significantly reducing the inhibition rate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16333103      PMCID: PMC1317233          DOI: 10.1128/JCM.43.12.6091-6097.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Evaluation of three commercial detection systems for Mycobacterium tuberculosis where clinical diagnosis is difficult.

Authors:  T J Brown; E G Power; G L French
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

2.  Commercial polymerase chain reaction test (Amplicor set) in the diagnosis of smear-negative pulmonary tuberculosis from sputum and bronchoalveolar lavage.

Authors:  F Salajka; L Mezensky; A Pokorny
Journal:  Monaldi Arch Chest Dis       Date:  2000-02

3.  Multicenter study of a commercial, automated polymerase chain reaction system for the rapid detection of Mycobacterium tuberculosis in respiratory specimens in routine clinical practice.

Authors:  M Bogard; J Vincelette; R Antinozzi; R Alonso; T Fenner; J Schirm; D Aubert; C Gaudreau; E Sala; M J Ruiz-Serrano; H Petersen; L A Oostendorp; H Burkardt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-10       Impact factor: 3.267

4.  Efficacy of centrifugation as a method of concentrating tubercle bacilli.

Authors:  G C KLEIN; M MALTZ; M M CUMMINGS; C H FISH
Journal:  Am J Clin Pathol       Date:  1952-06       Impact factor: 2.493

5.  Comparison of two automated DNA amplification systems with a manual one-tube nested PCR assay for diagnosis of pulmonary tuberculosis.

Authors:  K Y Yuen; W C Yam; L P Wong; W H Seto
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

6.  Clinical evaluation of the Roche AMPLICOR PCR Mycobacterium tuberculosis test for detection of M. tuberculosis in respiratory specimens.

Authors:  J S Bergmann; G L Woods
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

7.  Evaluation of sputum decontamination methods for Mycobacterium tuberculosis using viable colony counts and flow cytometry.

Authors:  Tamara V N Burdz; Joyce Wolfe; Amin Kabani
Journal:  Diagn Microbiol Infect Dis       Date:  2003-11       Impact factor: 2.803

8.  Diagnosis of tuberculosis by Amplicor Mycobacterium tuberculosis test: a multicenter study.

Authors:  E Carpentier; B Drouillard; M Dailloux; D Moinard; E Vallee; B Dutilh; J Maugein; E Bergogne-Berezin; B Carbonnelle
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  Processing respiratory specimens with C18-carboxypropylbetaine: development of a sediment resuspension buffer that contains lytic enzymes to reduce the contamination rate and lecithin to alleviate toxicity.

Authors:  C G Thornton; K M MacLellan; T L Brink; D M Wolfe; O J Llorin; S Passen
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

10.  Novel method for processing respiratory specimens for detection of mycobacteria by using C18-carboxypropylbetaine: blinded study.

Authors:  C G Thornton; K M MacLellan; T L Brink; D E Lockwood; M Romagnoli; J Turner; W G Merz; R S Schwalbe; M Moody; Y Lue; S Passen
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

View more
  3 in total

1.  Is real-time PCR better than conventional PCR for Mycobacterium tuberculosis complex detection in clinical samples?

Authors:  Enrico Tortoli; Pasquale Urbano; Fiorella Marcelli; Tullia M Simonetti; Daniela M Cirillo
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

Review 2.  Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.

Authors:  Linda M Parsons; Akos Somoskövi; Cristina Gutierrez; Evan Lee; C N Paramasivan; Alash'le Abimiku; Steven Spector; Giorgio Roscigno; John Nkengasong
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 3.  Chinese Expert Consensus on the Nucleic Acid Detection of SARS-CoV-2.

Authors:  Zijie Liu; Yongqing Tong; Jun Wu; Lutao Du; Chaojun Wei; Wei Cui; Yongtong Cao; Ming Chen; Zhen Cai; Wei Chen; Haitao Ding; Ming Guan; Wei Guo; Chunfang Gao; Xiaoke Hao; Chengjin Hu; Shan Huang; Yanfang Jiang; Jinming Li; Ping Li; Zhuo Li; Liang Ming; Shiyang Pan; Zuojun Shen; Jianrong Su; Ziyong Sun; Hui Wang; Junjun Wang; Bin Xu; Nong Yu; Lei Zheng; Yi Zhang; Xin Zhang; Ying Zhang; Yong Duan; Chengbin Wang
Journal:  Ann Transl Med       Date:  2020-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.